Clinical Trial Update: A Clinical Study Exploring the Safety, Efficacy and Cell Metabolic Kinetics of Universal Car-t Cell Injection in CD19 and / or CD20 Positive Relapsed / Refractory B-cell Acute Lymphoblastic Leukemia in Adolescents, Children and Adults [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating safety, efficacy, and cell metabolic kinetics of universal CAR-T cell therapy targeting CD19 and/or CD20 in relapsed/refract…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• Universal CAR-T Cell Therapy

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: ALL (Acute B-Lymphoblastic Leukemia) | EARLY_Phase 1 | Status: RECRUITING